课题基金 / 基金详情

Integrative Pharmacological Sciences Training Program (IPSTP)

Integrative Pharmacological Sciences Training Program (IPSTP)
综合药理学科学培训计划(IPSTP)
批准号:
10617778
负责人:
ANNE M. DORRANCE
金额:
$40.83万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-07-01 至 2026-06-30

项目摘要

项目成果

ANNE M. DORRANCE的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary / Abstract The Integrative Pharmacological Sciences Training Program (IPSTP) at Michigan State University is designed to support 2nd and 3rd year Ph.D. students pursuing dissertation research projects in the pharmacological sciences. Trainees and training faculty are drawn from 7 departmental Ph.D. programs (Biochemistry & Molecular Biology, Chemistry, Chemical Engineering and Materials Science, Microbiology & Molecular Genetics, Neuroscience, Pharmacology & Toxicology, and Physiology). The IPSTP will provide students with enhanced training in the fields of in vivo pharmacology, drug discovery, and big data. The research expertise of IPSTP training faculty is clustered into three overlapping themes: 1) the intersection of molecular mechanisms of disease with novel therapeutic design; 2) integration of endocrine and metabolic derangements with cancer and cardiovascular processes; and, 3) application of systems biology and bioinformatics to understand drug mechanisms and disease. Funds are requested to support 8 students (4 students entering the program per year). Dr. Neubig and Dr. Dorrance will serve as Co-Directors, Dr. Leinninger and Dr. Luyendyk will serve as Associate Directors. The Directors will be assisted by an Executive Committee composed of representatives from the programs and 2 student representatives. The program is also guided by an External Advisory Committee of experts from Pharmacology Ph.D. programs and the pharmaceutical industry. There are 8 core elements to the training plan: 1) a research project that leads to a Ph.D. dissertation and a contribution to knowledge in the pharmacological sciences; 2) three week-long intensive boot camps in drug discovery, in vivo pharmacology, and computational chemistry/big data; 3) a three-course curriculum in pharmacology and biostatistics, 4) training in scientific rigor and reproducibility 5) a Professional Development Forum; 6) participation in an annual program retreat; 7) a monthly journal club and chalk talk program, and 8) an individualized development plan program. Students will be expected to participate in the last four elements both during their direct T32 support period and for subsequent years until graduation. Trainees are also required to attend the Responsible Conduct of Research (RCR) workshop series provided by the Graduate School and program-specific RCR activities. Supplemental activities available to trainees include: 1) teaching opportunities; 2) participation in the NIH-funded MSU BEST program, and 3) field-trips to regional sites for non-academic careers. The IPSTP has developed a comprehensive plan to recruit highly qualified students including under-represented minority students. We have also developed comprehensive plans for program and student evaluation. Mentor training will also be required for all IPSTP program faculty and the quality of the mentoring received by the students will be assessed. The IPSTP will provide trainees with excellent research and professional training and will prepare them for research careers in academia, industry and government.
期刊论文(20)
专著(0)
科研奖励(0)
会议论文
Beta2-adrenoreceptor agonist clenbuterol produces transient decreases in alpha-synuclein mRNA but no long-term reduction in protein.
β2-肾上腺素受体激动剂clenbuterol会在α-核蛋白mRNA中产生短暂的降低,但蛋白质的长期降低没有。
DOI: 10.1038/s41531-022-00322-x
发表时间: 2022-05-24
期刊: NPJ PARKINSONS DISEASE
影响因子: 8.7
作者: [Patterson, Joseph R., Hirst, Warren D., Howe, Jacob W., Russell, Christopher P., Cole-Strauss, Allyson, Kemp, Christopher J., Duffy, Megan F., Lamp, Jared, Umstead, Andrew, Kubik, Michael, Stoll, Anna C., Vega, Irving E., Steece-Collier, Kathy, Chen, Yi, Campbell, Anne C., Nezich, Catherine L., Glajch, Kelly E., Sortwell, Caryl E.]
通讯作者: Sortwell, Caryl E.
Exploring structural effects in a new class of NRF2 inhibitors
探索新型 NRF2 抑制剂的结构效应
DOI: 10.1039/d2md00211f
发表时间: 2023
期刊: RSC Medicinal Chemistry
影响因子: 4.1
作者: [Hou, Zhilin, Lockwood, Lizbeth, Zhang, Di, Occhiuto, Christopher J., Mo, Linqing, Aldrich, Kelly E., Stoub, Hayden E., Gallo, Kathleen A., Liby, Karen T., Odom, Aaron L.]
通讯作者: Odom, Aaron L.
DOI: 10.3390/antiox12010116
发表时间: 2023-01-03
期刊: ANTIOXIDANTS
影响因子: 7
作者: [Moerland, Jessica A., Leal, Ana S., Lockwood, Beth, Demireva, Elena Y., Xie, Huirong, Krieger-Burke, Teresa, Liby, Karen T.]
通讯作者: Liby, Karen T.
DOI: 10.1128/msphere.00663-22
发表时间: 2023-04-20
期刊: mSphere
影响因子: 4.8
作者: []
通讯作者:
15
    Vascular cognitive impairment in hypertension; identification of an age appropriate model.
    • 批准号:
      10461131
    • 项目类别:
    • 资助金额:
      $23.48万
    • 财政年份:
      2021
    • 负责人:
      ANNE M. DORRANCE
    • 依托单位:
    Integrative Pharmacological Sciences Training Program (IPSTP)
    • 批准号:
      10268599
    • 项目类别:
    • 资助金额:
      $37.39万
    • 财政年份:
      2021
    • 负责人:
      ANNE M. DORRANCE
    • 依托单位:
    Vascular cognitive impairment in hypertension; identification of an age appropriate model.
    • 批准号:
      10313508
    • 项目类别:
    • 资助金额:
      $19.56万
    • 财政年份:
      2021
    • 负责人:
      ANNE M. DORRANCE
    • 依托单位:
    Integrative Pharmacological Sciences Training Program (IPSTP)
    • 批准号:
      10424560
    • 项目类别:
    • 资助金额:
      $40.01万
    • 财政年份:
      2021
    • 负责人:
      ANNE M. DORRANCE
    • 依托单位:
    海外基金